Ali Amouri

610 total citations
38 papers, 448 citations indexed

About

Ali Amouri is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Ali Amouri has authored 38 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 11 papers in Genetics and 10 papers in Epidemiology. Recurrent topics in Ali Amouri's work include Inflammatory Bowel Disease (10 papers), Microscopic Colitis (4 papers) and Immune Cell Function and Interaction (4 papers). Ali Amouri is often cited by papers focused on Inflammatory Bowel Disease (10 papers), Microscopic Colitis (4 papers) and Immune Cell Function and Interaction (4 papers). Ali Amouri collaborates with scholars based in Tunisia, Portugal and France. Ali Amouri's co-authors include N. Tahri, Hatem Masmoudi, Olfa Abida, Ali Gargouri, Carlos Penha‐Gonçalves, Abdelmajid Khabir, Emmanuelle Maguin, Adam Lesner, Lobna Ayadi and Bochra Gargouri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Medical Microbiology.

In The Last Decade

Ali Amouri

36 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Amouri Tunisia 14 127 104 103 84 82 38 448
Giuseppe Biscaglia Italy 15 252 2.0× 127 1.2× 155 1.5× 77 0.9× 111 1.4× 37 681
Pedro Russo Portugal 10 133 1.0× 123 1.2× 63 0.6× 46 0.5× 72 0.9× 29 473
Sean Flynn United States 5 123 1.0× 82 0.8× 139 1.3× 46 0.5× 41 0.5× 14 370
Gennett M. Myhre United States 6 125 1.0× 96 0.9× 114 1.1× 91 1.1× 67 0.8× 6 453
Karen Dubois‐Camacho Chile 11 180 1.4× 71 0.7× 135 1.3× 161 1.9× 105 1.3× 20 471
Rafael Barreto‐Zúñiga Mexico 14 116 0.9× 246 2.4× 110 1.1× 97 1.2× 108 1.3× 48 532
Kathleen S. Cormier United States 6 140 1.1× 150 1.4× 70 0.7× 140 1.7× 108 1.3× 7 452
Yuji Nishio Japan 14 71 0.6× 191 1.8× 164 1.6× 170 2.0× 87 1.1× 38 528
Ranji Hayashi Japan 10 86 0.7× 99 1.0× 33 0.3× 159 1.9× 45 0.5× 24 357
Giuseppe Corritore Italy 17 164 1.3× 160 1.5× 233 2.3× 202 2.4× 43 0.5× 26 600

Countries citing papers authored by Ali Amouri

Since Specialization
Citations

This map shows the geographic impact of Ali Amouri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Amouri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Amouri more than expected).

Fields of papers citing papers by Ali Amouri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Amouri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Amouri. The network helps show where Ali Amouri may publish in the future.

Co-authorship network of co-authors of Ali Amouri

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Amouri. A scholar is included among the top collaborators of Ali Amouri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Amouri. Ali Amouri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mnif, Basma, et al.. (2024). Assessment of histology's performance compared with PCR in the diagnosis of Helicobacter pylori infection. Future Science OA. 10(1). FSO976–FSO976. 4 indexed citations
2.
Frikha, F., et al.. (2023). Biclonal Gammopathies in South Tunisia: Clinical and Biological Characteristics. Laboratory Medicine. 54(5). 464–468. 1 indexed citations
3.
Jablaoui, Amin, Vincent Mariaule, Aïcha Kriaa, et al.. (2023). Serine proteases and metalloproteases are highly increased in irritable bowel syndrome Tunisian patients. Scientific Reports. 13(1). 17571–17571. 4 indexed citations
4.
Jablaoui, Amin, Aïcha Kriaa, Héla Mkaouar, et al.. (2020). Fecal Serine Protease Profiling in Inflammatory Bowel Diseases. Frontiers in Cellular and Infection Microbiology. 10. 21–21. 71 indexed citations
5.
Ali, Hawa M., Ali Amouri, H. Fourati, et al.. (2018). Ontology-Based Approach for Liver Cancer Diagnosis and Treatment. Journal of Digital Imaging. 32(1). 116–130. 16 indexed citations
6.
Abida, Olfa, et al.. (2017). Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease. Journal of Digestive Diseases. 18(11). 625–633. 15 indexed citations
7.
Aloulou, Hajer, Syrine Gallas, I. Chabchoub, et al.. (2016). Clinical and Genetic Characterization of 26 Tunisian Patients with Allgrove Syndrome. Archives of Medical Research. 47(2). 105–110. 19 indexed citations
8.
Amouri, Ali, Isabel Marques, Olfa Abida, et al.. (2014). Autoimmune diseases association study with the KIAA1109–IL2–IL21 region in a Tunisian population. Molecular Biology Reports. 41(11). 7133–7139. 11 indexed citations
9.
Amouri, Ali, Isabel Marques, Olfa Abida, et al.. (2013). Association of ZAP70 and PTPN6 , but Not BANK1 or CLEC2D , with Inflammatory Bowel Disease in the Tunisian Population. Genetic Testing and Molecular Biomarkers. 17(4). 321–326. 17 indexed citations
10.
Amouri, Ali, Isabel Marques, Olfa Abida, et al.. (2013). Polymorphisms in the IL2RA and IL2RB Genes in Inflammatory Bowel Disease Risk. Genetic Testing and Molecular Biomarkers. 17(11). 833–839. 28 indexed citations
11.
Mahfoudh, Nadia, et al.. (2013). Association Study of MICA-TM Polymorphism with Inflammatory Bowel Disease in the South Tunisian Population. Genetic Testing and Molecular Biomarkers. 17(8). 615–619. 4 indexed citations
12.
Gargouri, Bochra, et al.. (2013). Oxidative stress markers in intestinal mucosa of Tunisian inflammatory bowel disease patients. Saudi Journal of Gastroenterology. 19(3). 131–131. 40 indexed citations
13.
Amouri, Ali, et al.. (2012). Inflammatory Bowel Disease: Susceptibility and Disease Heterogeneity Revealed by Human Leukocyte Antigen Genotyping. Genetic Testing and Molecular Biomarkers. 16(6). 482–487. 16 indexed citations
14.
Amouri, Ali, N. Tahri, Lobna Ayadi, et al.. (2012). High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis. Familial Cancer. 11(3). 503–508. 10 indexed citations
15.
Amouri, Ali, Isabel Marques, Olfa Abida, et al.. (2011). The CREM gene is involved in genetic predisposition to inflammatory bowel disease in the Tunisian population. Human Immunology. 72(12). 1204–1209. 14 indexed citations
16.
Amouri, Ali, et al.. (2011). Contribution of immunofluorescence to identification and characterization of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Indian Journal of Gastroenterology. 30(5). 229–232. 7 indexed citations
17.
Ayadi, Lobna, Abdelmajid Khabir, Ali Amouri, et al.. (2011). Expression of COX-2 and E-cadherin in Tunisian patients with colorectal adenocarcinoma. Acta Histochemica. 114(6). 577–581. 23 indexed citations
18.
Ayadi, Lobna, Abdelmajid Khabir, Lamia Kallel, et al.. (2010). Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma. Tumor Biology. 31(5). 503–511. 16 indexed citations
19.
Amouri, Ali, et al.. (2008). Prise en charge de la réactivation virale B au cours d’un traitement chimiothérapique ou immunosuppresseur. La Presse Médicale. 37(11). 1591–1598. 1 indexed citations
20.
Tahri, N., et al.. (2003). [Meteorologic conditions and esophageal varices rupture].. PubMed. 154(8). 509–14. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026